George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and as such streamlining and speeding up the process of commencing a trial in Hong Kong.

“We are very pleased to announce the receipt of our Hong Kong Wholesale Dealer licence,” Evon Hui, Associate Director, East Asia said. “It is a strong endorsement of the work we are currently undertaking in Hong Kong and will allow us to build on our already robust operational delivery.”

George Clinical Hong Kong can now apply to import and/or export license(s) for Investigational Product shipments to and from the investigational sites after regulatory approval. Improving the start-up times by streamlining the process for George Clinical’s sponsors.